David R. Lewis

David R. Lewis Recent News

Morgan Stanley Sees Balance Sheet & Pipeline As More Critical For Johnson & Johnson
UPDATE: Morgan Stanley Raises PT On Edwards Lifesciences Corp., Say Upside Now Tied To Bull Case
UPDATE: Morgan Stanley Reiterates On Nevro On Improving Margins
Morgan Stanley Believes That Delays Temper Enthusiasm For Intuitive Surgical
UPDATE: Morgan Stanley Reiterates On Baxter International On Value Creation Through Spin
Morgan Stanley: CareFusion Corporation Deal Offers 'Good, Not Great' Returns For Becton, Dickinson And Co.
Morgan Stanley Sees Ways For Medtronic, Inc. To Create Value
UPDATE: Morgan Stanley Reiterates On Medtronic, Inc. On Proposed Treasury Rules
Morgan Stanley Remains Positive On Stryker Corporation
Morgan Stanley Has Critical Questions For Stryker Corporation Going Into Investor Day
Morgan Stanley Sees Johnson & Johnson Taking Rx Estimates Higher
Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson
Morgan Stanley Sees Attractive Risk/Reward For Medtronic
Morgan Stanley Sees US Market Acceleration Driving Upside Potential For Edwards Lifesciences
Morgan Stanley Ponders How Potential Danone Acquisition Could Affect Hospira
Morgan Stanley Modestly Adjusts Share Assumptions For Edwards Lifesciences
UPDATE: Morgan Stanley Reiterates On Abbott Laboratories As Growth and Margins Are Set To Continue
Morgan Stanley Sees Meaningful '15 Headwind For Johnson & Johnson
Morgan Stanley Sees Underappreciated Upside Drivers For Zimmer
Morgan Stanley Sees Execution Priced In For Becton, Dickinson and Co.
Morgan Stanley Sees Growth Acceleration As Key To Thesis For Abbott Laboratories
Morgan Stanley Sees End-Market Pressure On Hill-Rom
UPDATE: Morgan Stanley Upgrades Medtronic Following Acquisition Of COV